Next we compared percentages of circulating CXCR5+ PD1+/CD4+ cells in SLE patients with varying levels of disease activity, as assessed by the SLEDAI score at the time blood was obtained. This evidence concerns the gene CXCR5 and systemic lupus erythematosus.